amikacin has been researched along with colistimethate sodium in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fiegel, J; Sommerfeld Ross, S | 1 |
Fiel, SB | 1 |
Almirante, B; Basas, J; Gainza, E; Gainza, G; Gavaldà, J; Gomis, X; Hernandez, RM; Igartua, M; Palau, M; Pastor, M; Vairo, C | 1 |
Alaminos, M; Bermejo-Casares, F; Campos, F; Carriel, V; Chato-Astrain, I; Chato-Astrain, J; Gainza, G; García-García, ÓD; Garzón, I; Oruezabal, RI; Ponce-Polo, Á; Sánchez-Porras, D; Vairo, C; Villar-Vidal, M; Villullas, S | 1 |
1 review(s) available for amikacin and colistimethate sodium
Article | Year |
---|---|
Aerosolized antibiotics in cystic fibrosis: an update.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Aztreonam; Colistin; Cystic Fibrosis; Equipment Design; Humans; Levofloxacin; Nebulizers and Vaporizers; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Tobramycin | 2014 |
3 other study(ies) available for amikacin and colistimethate sodium
Article | Year |
---|---|
Nutrient dispersion enhances conventional antibiotic activity against Pseudomonas aeruginosa biofilms.
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Citrates; Colistin; Culture Media; Drug Resistance, Multiple, Bacterial; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Confocal; Polymyxin B; Pseudomonas aeruginosa; Sodium Citrate; Succinic Acid | 2012 |
In vitro and in vivo antimicrobial activity of sodium colistimethate and amikacin-loaded nanostructured lipid carriers (NLC).
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Colistin; Drug Carriers; Drug Resistance, Bacterial; Humans; Lipids; Nanostructures; Pseudomonas aeruginosa | 2020 |
Generation of a novel human dermal substitute functionalized with antibiotic-loaded nanostructured lipid carriers (NLCs) with antimicrobial properties for tissue engineering.
Topics: Amikacin; Anti-Bacterial Agents; Biocompatible Materials; Cell Proliferation; Cell Survival; Cells, Cultured; Colistin; Drug Carriers; Fibroblasts; Humans; Lipids; Nanostructures; Skin, Artificial; Tissue Engineering | 2020 |